Covetrus to Present at the J.P. Morgan 38th Annual Healthcare Conference
Covetrus to Present at the J.P. Morgan 38th Annual Healthcare Conference
Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that the Company will be participating in theJ.P. Morgan 38th Annual Healthcare Conferencein San Francisco, CA.
Covetrus acting president and chief executive officer Benjamin Wolin is scheduled to present on Wednesday, January 15, 2020 at 9:30 a.m. Pacific Time. A live webcast of the presentation, as well as an archived recording, will be available on the Investor Relations section of the Company’s website athttps://ir.covetrus.com/investors/events-and-presentations.
科維特魯斯代理總裁兼首席執行官本傑明·沃林定於 2020 年 1 月 15 日（週三）太平洋時間上午 9:30 出席。該公司網站的投資者關係部分將提供演示文稿的現場直播以及存檔記錄，網址為 https://ir.covetrus.com/investors/events-and-presentations。
About Covetrus
關於科維崔
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more atcovetrus.com.
Covetrus 是一家全球性的動物健康科技和服務公司，致力於促進獸醫實踐合作夥伴的能力，以推動改善健康和財務成果。我們將產品、服務和技術整合到單一平台中，讓我們的客戶能夠獲得最佳工作所需的解決方案和見解。我們對動物和照顧動物的人的福祉的熱情驅使我們推動了獸醫世界的發展。Covetrus 總部位於緬因州波特蘭，擁有 5,500 多名員工，為全球超過 10 萬名客戶提供服務。了解更多。
Forward-Looking Statements
前瞻性陳述
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.
本新聞稿包含某些經修訂的《1933 年證券法》第 27A 條所指的前瞻性陳述，以及經修訂的 1934 年證券交易法第 21E 條，並涉及風險和不確定性，包括有關我們計劃，目標，期望和意圖的陳述。這些陳述受到許多風險和不確定性的影響。可能對本港業務及前景造成不利影響的因素，載於我們向證券及交易事務監察委員會提交的公開文件。我們的前瞻性陳述基於當前的信念和對管理層的期望 球隊 並且，除法律要求外，我們不承擔任何義務對本發布中包含的前瞻性陳述進行任何修訂，或對其進行更新以反映本發布日期之後發生的事件或情況，無論是由於新信息，未來發展或其他原因造成的。投資者應注意不要對這些前瞻性陳述作出不當的依賴。
View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005015/en/
在商業網站上查看原始碼版本：https://www.businesswire.com/news/home/20200103005015/en/
Contacts
联系人
Nicholas Jansen, Investor Relations
投資者關係-尼古拉斯·詹森
nicholas.jansen@covetrus.com| (207) 550-8106
nicholas.jansen@covetrus.com | (207) 550-8106
Kiní Schoop, Public Relations
中學校，公共關係
kini.schoop@covetrus.com| (207) 550-8018
kini.schoop@covetrus.com | (207) 550-8018
譯文內容由第三人軟體翻譯。